SHORT MINI FUTURE WARRANT - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 11:56:24 17/05/2024 pm IST | ||
| 4.66 EUR | -0.21% |
|
| Current month | -1.89% | ||
| 1 month | +6.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 4.66 | -0.21% |
| 16/24/16 | 4.67 | +1.08% |
| 15/24/15 | 4.62 | -0.43% |
| 14/24/14 | 4.64 | +0.65% |
| 13/24/13 | 4.61 | -0.86% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 11:56 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GZ4MP3 |
| ISIN | DE000GZ4MP36 |
| Date issued | 02/12/2022 |
| Strike | 94.83 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.78 € |
|---|---|
| Lowest since issue | 1.509 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
44.03
USD
Average target price
53.19
USD
Spread / Average Target
+20.81%
- Stock Market
- Certificates
- Certificat
